Matrix Metalloproteinase Inhibition Decreases Ischemia-Reperfusion Injury After Lung Transplantation

Paola M. Soccal; Yvan Gasche; Douglas N. Miniati; Grant Hoyt; Gerald J. Berry; Ramona L. Doyle; James Theodore; Robert C. Robbins

doi:10.1046/j.1600-6135.2003.00277.x

JOURNAL ARTICLE

Matrix Metalloproteinase Inhibition Decreases Ischemia-Reperfusion Injury After Lung Transplantation

Paola M. Soccal Yvan Gasche Douglas N. Miniati Grant Hoyt Gerald J. Berry Ramona L. Doyle James Theodore Robert C. Robbins

Year: 2003 Journal: American Journal of Transplantation Vol: 4 (1)Pages: 41-50 Publisher: Elsevier BV

DOI: 10.1046/j.1600-6135.2003.00277.x

Get Full-Text PDF Get Analytical Report

Keywords:

Medicine Ischemia Transplantation Lung transplantation Lung Reperfusion injury Matrix metalloproteinase Vascular permeability Extravasation Evans Blue Matrix metalloproteinase inhibitor Anesthesia Pathology Pharmacology Internal medicine

Metrics

Cited By

1.69

FWCI (Field Weighted Citation Impact)

Refs

0.83

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Transplantation: Methods and Outcomes

Health Sciences → Medicine → Surgery

Cardiac Ischemia and Reperfusion

Health Sciences → Medicine → Pathology and Forensic Medicine

Nitric Oxide and Endothelin Effects

Health Sciences → Medicine → Physiology

Matrix Metalloproteinase Inhibition Decreases Ischemia-Reperfusion Injury After Lung Transplantation

Metrics

Citation History

Topics

Related Documents

MATRIX METALLOPROTEINASE INHIBITION DECREASES ISCHEMIA-REPERFUSION INJURY AFTER LUNG TRANSPLANTATION.

Caspase Inhibition Improves Ischemia-Reperfusion Injury After Lung Transplantation

Inhibition of DNA methylation attenuates lung ischemia–reperfusion injury after lung transplantation

ACTIVATION OF MATRIX METALLOPROTEINASE 9 DURING LUNG ISCHEMIA-REPERFUSION INJURY.

N-Acetylcysteine Attenuates Lung Ischemia–Reperfusion Injury After Lung Transplantation